Clinical trial
Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation
NCT05627505 is registered in ClinicalTrials.gov with Qingyuan Zhan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diagnostic and Prognostic Value of Lung Microbiota in Early Lung Infection After Lung Transplantation
- Lead sponsor
- Qingyuan Zhan
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- November 20, 2022
- Completion date
- December 30, 2023
- Enrollment
- 80 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.